Risk for nevus transformation and melanoma proliferation and invasion during natalizumab treatment: four years of dermoscopic follow-up with immunohistological studies and proliferation and invasion assays

Saved in:
Bibliographic Details
Published inJAMA dermatology (Chicago, Ill.) Vol. 150; no. 8; p. 901
Main Authors Pharaon, Momen, Tichet, Mélanie, Lebrun-Frénay, Christine, Tartare-Deckert, Sophie, Passeron, Thierry
Format Journal Article
LanguageEnglish
Published United States 01.08.2014
Subjects
Antibodies, Monoclonal, Humanized - pharmacology
Cell Line, Tumor
Cell Movement - drug effects
Cell Proliferation - drug effects
Cell Transformation, Neoplastic
Dermoscopy
Follow-Up Studies
Humans
Immunohistochemistry
Immunologic Factors - pharmacology
Integrin beta3 - analysis
Melanoma - chemistry
Melanoma - pathology
Multiple Sclerosis - drug therapy
Natalizumab
Nevus - chemistry
Nevus - pathology
Osteonectin - analysis
Skin Neoplasms - chemistry
Skin Neoplasms - pathology
Online AccessGet more information

Cover

Author Lebrun-Frénay, Christine
Pharaon, Momen
Tichet, Mélanie
Tartare-Deckert, Sophie
Passeron, Thierry
Author_xml – sequence: 1
  givenname: Momen
  surname: Pharaon
  fullname: Pharaon, Momen
  organization: Department of Dermatology, Archet 2 Hospital, Centre Hospitalier Universitaire (CHU) Nice, Nice, France
– sequence: 2
  givenname: Mélanie
  surname: Tichet
  fullname: Tichet, Mélanie
  organization: Institut National de la Santé et de la Recherche Médicale (INSERM), U1065, Team 11, Centre Méditerranéen de Médecin Moléculaire (C3M), Nice, France
– sequence: 3
  givenname: Christine
  surname: Lebrun-Frénay
  fullname: Lebrun-Frénay, Christine
  organization: Department of Neurology, Pasteur Hospital, CHU Nice, Nice, France
– sequence: 4
  givenname: Sophie
  surname: Tartare-Deckert
  fullname: Tartare-Deckert, Sophie
  organization: Institut National de la Santé et de la Recherche Médicale (INSERM), U1065, Team 11, Centre Méditerranéen de Médecin Moléculaire (C3M), Nice, France
– sequence: 5
  givenname: Thierry
  surname: Passeron
  fullname: Passeron, Thierry
  organization: Department of Dermatology, Archet 2 Hospital, Centre Hospitalier Universitaire (CHU) Nice, Nice, France4INSERM, U1065, Team 12, C3M, Nice, France
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24919481$$D View this record in MEDLINE/PubMed
BookMark eNp9kN1KAzEQhYMotta-guQFtmay6f54J8U_KAii12Wym7TRTbIkuy31HX0nt_7gnXMzHA58c86ckWPnnSLkAtgMGIPLV7RYq2Cx882MM0hnpQA4ImMOWZFkrBAjMo3xlQ1TMCZSOCUjLkooRQFj8vFk4hvVPlCntn2kXUAXBznwjHcUXU2tatB5i7QNvjFahT_LuC3Gg6j7YNyaOuywMe-9RTmQFHZWue5qwPeB7hWGSL2mh7Q-Vr411eA0jd8lfUt3pttQY23v_MbEoYxfmwobGru-Nip-nfsnAMaI-3hOTjQ2UU1_9oS83N48L-6T5ePdw-J6mSDP8y4pQRQiLxFkprgQOdMS5wyQ81zOBVRpXqU6BQlMZ3Uq86LOuEBZ5lIyBM35hFx8c9teWlWv2mAshv3q96_8E5WzhfQ
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1001/jamadermatol.2013.9411
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 2168-6084
ExternalDocumentID 24919481
Genre Research Support, Non-U.S. Gov't
Journal Article
Observational Study
GroupedDBID 0R~
4.4
53G
AAWTL
ABJNI
ACGFS
ADBBV
AENEX
AFOSN
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AMJDE
ANMPU
BCGUY
BRYMA
C45
CGR
CUY
CVF
EBD
EBS
ECM
EIF
EJD
EMOBN
EX3
NPM
OB3
OBH
OGROG
OHH
OVD
PQQKQ
RAJ
SV3
TEORI
WOW
ID FETCH-LOGICAL-a277t-9148479a1b6e24470fba501a227b541c37c3f31b10f6d3b78d624ab97bb0a1f22
IngestDate Thu May 23 23:21:05 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-a277t-9148479a1b6e24470fba501a227b541c37c3f31b10f6d3b78d624ab97bb0a1f22
PMID 24919481
ParticipantIDs pubmed_primary_24919481
PublicationCentury 2000
PublicationDate 2014-Aug
PublicationDateYYYYMMDD 2014-08-01
PublicationDate_xml – month: 08
  year: 2014
  text: 2014-Aug
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle JAMA dermatology (Chicago, Ill.)
PublicationTitleAlternate JAMA Dermatol
PublicationYear 2014
SSID ssj0000800431
Score 2.2231722
SourceID pubmed
SourceType Index Database
StartPage 901
SubjectTerms Antibodies, Monoclonal, Humanized - pharmacology
Cell Line, Tumor
Cell Movement - drug effects
Cell Proliferation - drug effects
Cell Transformation, Neoplastic
Dermoscopy
Follow-Up Studies
Humans
Immunohistochemistry
Immunologic Factors - pharmacology
Integrin beta3 - analysis
Melanoma - chemistry
Melanoma - pathology
Multiple Sclerosis - drug therapy
Natalizumab
Nevus - chemistry
Nevus - pathology
Osteonectin - analysis
Skin Neoplasms - chemistry
Skin Neoplasms - pathology
Title Risk for nevus transformation and melanoma proliferation and invasion during natalizumab treatment: four years of dermoscopic follow-up with immunohistological studies and proliferation and invasion assays
URI https://www.ncbi.nlm.nih.gov/pubmed/24919481
Volume 150
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9swEBabFkovpe930aHQQ3GwZPnVW2m7LIVdSpuFvS2SLdEUxw6beEv2P_Y_dUaSH9l0-7qY4EGy8HyRRuNvPhHyMoUlXQleBJEui0BESREoVqiAm0yUIlJ5aSXzD4-Sg2Px8SQ-2Zu8GrGW2rWaFhe_rCv5H6_CPfArVsn-g2f7TuEG_Ab_whU8DNe_8vFn5IUjT7DW5-0Kj3vog1BPMl7oStbNQiIPq0IWy2Ca1-cSU2VdpWKNiZz5RbuQaqCfY8LAwFBeb-AfYVkfJUzlDdayzAuwVFXzPWiXLp07x1qTxioYdzPqytEUvRzBlUOACF5uVluBMiwG9lly7VSi8Guzo43Yaa2qpqMkxieUnfZ1ACgp0ecjkOjqCCmOEVBhRf1AQlJnbR3se7ZALTeD3MKIbjCDNy_PdPBe9xVOX5rlV9-Pz5gw0fP1YMGzMytnSRYkoTubrl8GnACux3s2mtRz13hnsRkOOeheB1IFo2ku2FYDcNVyYSEIe12G8jh_tl4SAe9MEzJJMzyh5Mgnpb75oB_iwK7-3Wtq7Y4Jha99P5c2UTaYmt0mt_wuiL51kL5D9nR9l9w49DyPe-QHIpsClKlFNt1GNgXs0A7ZdAtW1tTBijpk0xGyaY_sNxRxTS2uaWPoCNe0xzVFXNNdXFOPa_u43wzA4fo-Od7_MHt3EPiDRwLJ03QNAYCAoC2XTCUawt80NErGIZOcpyoWrIjSIjIRUyw0SRmpNCsTLqTKU6VCyQznD8i1uqn1I0Jzqbk2sY51LrFoXRmeMxOzhKscGkaPyUPniNOlU5c57Vz05ErLU3JzgPUzct3AdKafQ2y8Vi8sMn4CLIPICQ
link.rule.ids 780
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Risk+for+nevus+transformation+and+melanoma+proliferation+and+invasion+during+natalizumab+treatment%3A+four+years+of+dermoscopic+follow-up+with+immunohistological+studies+and+proliferation+and+invasion+assays&rft.jtitle=JAMA+dermatology+%28Chicago%2C+Ill.%29&rft.au=Pharaon%2C+Momen&rft.au=Tichet%2C+M%C3%A9lanie&rft.au=Lebrun-Fr%C3%A9nay%2C+Christine&rft.au=Tartare-Deckert%2C+Sophie&rft.date=2014-08-01&rft.eissn=2168-6084&rft.volume=150&rft.issue=8&rft.spage=901&rft_id=info:doi/10.1001%2Fjamadermatol.2013.9411&rft_id=info%3Apmid%2F24919481&rft_id=info%3Apmid%2F24919481&rft.externalDocID=24919481